|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Acquired in-process research and development | |||||
| Intangible asset amortization | |||||
| Share-based compensation | |||||
| Acquisition accounting inventory fair value step-up adjustment | |||||
| Depreciation | |||||
| Non-cash interest expense | |||||
| Provision for losses on accounts receivable and inventory | |||||
| Deferred tax benefit | |||||
| Impairment of property, plant and equipment | |||||
| Intangible asset impairment charge | |||||
| Loss on disposal of a business | |||||
| Other non-cash transactions | |||||
| Changes in assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other assets | |||||
| Operating lease assets | |||||
| Other non-current assets | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Income taxes payable | |||||
| Deferred revenue | |||||
| Operating lease liabilities, less current portion | |||||
| Other non-current liabilities | |||||
| Other liabilities | |||||
| Net cash provided by operating activities | |||||
| Investing activities | |||||
| Acquisition of investments | |||||
| Asset acquisition, net of cash acquired | |||||
| Acquisition of intangible assets | |||||
| Acquisition of a business, net of cash acquired | |||||
| Proceeds from sale of a business | |||||
| Purchases of property, plant and equipment | |||||
| Acquired in-process research and development | |||||
| Proceeds from sale of an asset | |||||
| Proceeds from maturity of investments | |||||
| Net cash used in investing activities | |||||
| Financing activities | |||||
| Repayments of long-term debt | |||||
| Share repurchases | |||||
| Net proceeds from issuance of borrowings under credit agreement | |||||
| Net proceeds from issuance of Senior Secured Notes, due 2029 | |||||
| Payment of employee withholding taxes related to share-based awards | |||||
| Proceeds from employee equity incentive and purchase plans | |||||
| Repayment of 2024 Notes | |||||
| Payment of debt modification costs | |||||
| Net proceeds from issuance of 2030 Notes | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rates on cash and cash equivalents | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents, at beginning of period | |||||
| Cash and cash equivalents, at end of period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes, net of refunds | |||||
Loading...